γ-Secretase inhibitors repress thymocyte development

A major therapeutic target in the search for a cure to the devastating Alzheimer's disease is γ-secretase. This activity resides in a multiprotein enzyme complex responsible for the generation of Aβ42 peptides, precipitates of which are thought to cause the disease. γ-Secretase is also a critical component of the Notch signal transduction pathway; Notch signals regulate development and differentiation of adult self-renewing cells. This has led to the hypothesis that therapeutic inhibition of γ-secretase may interfere with Notch-related processes in adults, most alarmingly in hematopoiesis. Here, we show that application of γ-secretase inhibitors to fetal thymus organ cultures interferes with T cell development in a manner consistent with loss or reduction of Notch1 function. Progression from an immature CD4−/CD8− state to an intermediate CD4+/CD8+ double-positive state was repressed. Furthermore, treatment beginning later at the double-positive stage specifically inhibited CD8+ single-positive maturation but did not affect CD4+ single-positive cells. These results demonstrate that pharmacological γ-secretase inhibition recapitulates Notch1 loss in a vertebrate tissue and present a system in which rapid evaluation of γ-secretase-targeted pharmaceuticals for their ability to inhibit Notch activity can be performed in a relevant context.

[1]  T. Schroeder,et al.  Notch signalling via RBP‐J promotes myeloid differentiation , 2000, The EMBO journal.

[2]  H. Macdonald,et al.  Notch1 Deficiency Dissociates the Intrathymic Development of Dendritic Cells and T Cells , 2000, The Journal of experimental medicine.

[3]  J. Lamb,et al.  Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. , 2000, International immunology.

[4]  R. Germain,et al.  The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate , 2000, Nature.

[5]  I. Bernstein,et al.  Inhibition of granulocytic differentiation by mNotch1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Sklar,et al.  Notch1-Induced Delay of Human Hematopoietic Progenitor Cell Differentiation Is Associated With Altered Cell Cycle Kinetics , 1999 .

[7]  J. Aster,et al.  Notch1 expression in early lymphopoiesis influences B versus T lineage determination. , 1999, Immunity.

[8]  B. Fowlkes,et al.  Notch Activity Influences the αβ versus γδ T Cell Lineage Decision , 1997, Cell.

[9]  M. Bevan,et al.  Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. , 2000, Immunity.

[10]  A. Goate,et al.  A common enzyme connects notch signaling and Alzheimer's disease. , 2000, Genes & development.

[11]  M. Moore,et al.  A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells. , 2000, Blood.

[12]  L. Lam,et al.  Identity of the β-Globin Locus Control Region Binding Protein HS2NF5 as the Mammalian Homolog of the Notch-regulated Transcription Factor Suppressor of Hairless* , 1998, The Journal of Biological Chemistry.

[13]  H. Macdonald,et al.  Inactivation of Notch1 in immature thymocytes does not perturb CD4 or CD8 T cell development , 2001, Nature Immunology.

[14]  D. Selkoe,et al.  Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. , 1999, Biochemistry.

[15]  H. Macdonald,et al.  Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.

[16]  H. Weintraub,et al.  The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. , 1994, Development.

[17]  D. Selkoe,et al.  In search of γ-secretase: Presenilin at the cutting edge , 2000 .

[18]  H. Petrie,et al.  The acquisition of CD4 and CD8 during the differentiation of early thymocytes in short-term culture. , 1989, International immunology.

[19]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[20]  M. Bhatia,et al.  The Notch Ligand Jagged-1 Represents a Novel Growth Factor of Human Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[21]  Iva Greenwald,et al.  Presenilin is required for activity and nuclear access of Notch in Drosophila , 1999, Nature.

[22]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[23]  M. Fortini,et al.  Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants , 1999, Nature.

[24]  Raphael Kopan,et al.  A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. , 2000, Molecular cell.

[25]  L. Lam,et al.  Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1* , 2000, The Journal of Biological Chemistry.

[26]  Raphael Kopan,et al.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.

[27]  Raphael Kopan,et al.  Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1 , 2000, Nature.

[28]  G. Weinmaster,et al.  An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.

[29]  M. Bevan,et al.  Notch signaling in T cell development. , 2000, Current opinion in immunology.

[30]  H. Kishi,et al.  A novel cell surface antigen, immature thymocyte antigen-1, is involved in the differentiation of murine thymocytes. , 1995, Journal of immunology.

[31]  C. Haass,et al.  Intramembrane proteolysis by presenilins , 2000, Nature Reviews Molecular Cell Biology.

[32]  A Gulino,et al.  Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. , 1999, International immunology.

[33]  B. Yankner,et al.  Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Bevan,et al.  Correlating notch signaling with thymocyte maturation. , 1998, Immunity.

[35]  I. Bernstein,et al.  Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. , 2000, Blood.

[36]  T. Amagai,et al.  Limited development capacity of the earliest embryonic murine thymus , 1995, European journal of immunology.

[37]  William J. Ray,et al.  A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain , 1999, Nature.

[38]  J. Hardy,et al.  Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases , 2000, Nature Cell Biology.

[39]  A. Bigas,et al.  Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. , 1999, Blood.

[40]  A. Bigas,et al.  Notch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines , 1998, Molecular and Cellular Biology.

[41]  I. Bernstein,et al.  A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. , 1994, Blood.

[42]  G. Weinmaster,et al.  Notch Signaling Enhances Survival and Alters Differentiation of 32D Myeloblasts1 , 2000, The Journal of Immunology.

[43]  I. Bernstein,et al.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling , 2000, Nature Medicine.

[44]  K. Tomita,et al.  The bHLH gene Hes1 is essential for expansion of early T cell precursors. , 1999, Genes & development.